About Unither
Unither is a company based in Paris (France) founded in 1993 was acquired by Ardian in November 2016. Unither has completed 1 acquisition, including Nanjing Ruinian Best Pharmaceutical. Unither operates in a competitive market with competitors including Akums, Jubilant Life Sciences, Recipharm, Nectar Lifesciences and CoreRx, among others.
- Headquarter Paris, France
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Idinvest Partners
& 11 more
-
Employee Count
Not available
- Investments & Acquisitions
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Unither
Investors in Unither
Unither has secured backing from 12 investors, including venture fund and institutional investors. Prominent investors backing the company include Idinvest Partners, IK Partners and GIC.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Sovereign wealth is managed and private equity investments are facilitated.
|
Locked | Locked | Locked | |
|
Private equity investments are directed toward small and medium-sized businesses.
|
Locked | Locked | Locked | |
|
Equity investments are provided to low and middle market companies.
|
Locked | Locked | Locked |
Investor details for Unither
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Unither
Unither has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Nanjing Ruinian Best Pharmaceutical.
Investment portfolio details for Unither
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Drug development services are provided in the pharmaceutical sector.
|
Locked | Locked | 2009 | Locked |
Complete acquisition details for Unither
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Unither
Detailed financials for Unither
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Unither Comparisons
Peer comparison for Unither
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Unither
Unither operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Akums, Jubilant Life Sciences, Recipharm, Nectar Lifesciences and CoreRx, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
CDMO focusing on spectrum of dosage forms and therapeutic segments
|
|
| Locked | Locked | Locked |
Company offering a suite of R&D and manufacturing services for small molecules and generics
|
|
| Locked | Locked | Locked |
Pharmaceutical development and manufacturing services are offered contractually.
|
|
| Locked | Locked | Locked |
Cephalosporin APIs and generic formulations are manufactured.
|
|
| Locked | Locked | Locked |
CDMO with a focus on early phase drug product development
|
Detailed competitors of Unither
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Unither
Complete news archive for Unither
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Unither
Unither was founded in 1993 and raised its 1st funding round 7 years after it was founded.
Unither is headquartered in Paris, France.
Founded in 1993 and headquartered in Paris, France, Unither operates as a contract development and manufacturing organization in the pharmaceutical sector. Various dosage forms, including blow-fill seals, liquid and powder stick packs, effervescent tablets, pharmaceutical bottles, suppositories, and pessaries, are produced. RD and manufacturing facilities are maintained in Europe, with an additional manufacturing site in North America and sales offices in Brazil.
Unither's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
Unither has made 1 acquisition, including Nanjing Ruinian Best Pharmaceutical.
Unither has 12 investors. Key investors include Idinvest Partners, IK Partners, GIC, Ministry of Economy, Finance and Industrial and Digital Sovereignty, and Ardian.